James F. Donohue

Statistics

Publications

Citations

5.2K

H-Index

Active since

1979

Affiliations

University of North Carolina at Chapel Hill(Current)

Research Triangle Park Foundation

University of California, Los Angeles

Baylor College of Medicine

Sunovion (United States)

James F. Donohue is an author at University of North Carolina at Chapel Hill specializing in pulmonology, chronic obstructive pulmonary disease, and pharmacotherapy.

ORCID

Publications per year

1979–2024

Publications

Efficacy of Salmeterol Xinafoate in the Treatment of COPD

Donald A. Mahler, James F. Donohue, Robert A. Barbee et al. · CHEST Journal · 1999 · 517 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol

James F. Donohue, J.A. van Noord, Eric Bateman et al. · CHEST Journal · 2002 · 469 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Charles Fogarty, Steven G. Kelsen et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 432 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Comparison of micro- and nano-size particle depositions in a human upper airway model

Z. Zhang, Clement Kleinstreuer, James F. Donohue et al. · Journal of Aerosol Science · 2004 · 323 citations

Natural Sciences, Bioengineering, Biomedical Engineering +13

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, David C. Dale, James F. Donohue et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 258 citations

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 63